AKT1 and cancer: Current studies have shown that formononetin can effectively inhibit the transduction of JAK/STAT signaling pathway and induce the inactivation of PKB/AKT pathway and MAPK pathway, which in turn can effectively inhibit the migration and invasion of cancer cells (Aliya et al., 2023).